FOXD3 Activators
FOXD3 Activators encompass a diverse range of compounds that can lead to the enhancement of the FOXD3 gene's functional activity by affecting various signaling pathways. Forskolin, by directly activating adenylate cyclase, increases intracellular cAMP levels, leading to the enhanced phosphorylation of CREB. CREB, once phosphorylated, can activate the transcription of FOXD3. Similarly, IBMX increases cAMP levels by inhibiting phosphodiesterases, leading to sustained activation of CREB and, consequently, FOXD3. Epinephrine and Prostaglandin E2 both elevate cAMP levels through their respective receptors, culminating in PKA activation which can enhance FOXD3 activity via CREB phosphorylation.
In addition to these cAMP-modulating agents, Cholera Toxin leads to continuous activation of adenylate cyclase via Gs alpha protein activation, resulting in increased cAMP and CREB-mediated activation of FOXD3. Retinoic Acid, through its receptor, can directly enhance the transcription of genes including FOXD3. Lithium and Biochanin A inhibit GSK-3β, a negative regulator of transcription factors, thereby potentially enhancing the functional activity of FOXD3. The Wnt pathway, when activated by agonists, leads to β-catenin stabilization, which can then enhance FOXD3 gene expression. Similarly, Dibutyryl-cAMP, a synthetic analog of cAMP, and PACAP, a natural peptide, both elevate cAMP levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylate cyclase, increasing cAMP levels. Elevated cAMP enhances CREB phosphorylation, which can lead to the activation of FOXD3 as CREB can bind to the promoter region of FOXD3, enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor that prevents cAMP degradation, thereby sustaining cAMP levels and CREB activation, which can enhance FOXD3 activity by increasing transcriptional activation signals. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, which via G protein signaling, increases intracellular cAMP, leading to activation of PKA and subsequent CREB activation, which can enhance FOXD3 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 activates the EP2 receptor, increasing cAMP production in the cell. This can lead to the activation of CREB, which may enhance FOXD3 activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates retinoic acid receptors that can bind to retinoic acid response elements in the promoter regions of target genes, which may include FOXD3, enhancing its transcriptional activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits GSK-3β, a kinase that can phosphorylate transcription factors. Inhibiting GSK-3β stabilizes transcription factors that might enhance FOXD3 activity. | ||||||
Wnt Agonist | 853220-52-7 | sc-222416 sc-222416A | 5 mg 25 mg | $157.00 $609.00 | 23 | |
Wnt pathway agonists stabilize β-catenin, which can interact with TCF/LEF transcription factors. This complex can upregulate genes including FOXD3, enhancing its activity. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate CREB, which could enhance the activity of FOXD3 by increasing transcriptional activation signals. | ||||||
Biochanin A | 491-80-5 | sc-205603 sc-205603A | 100 mg 250 mg | $77.00 $132.00 | ||
Biochanin A is an isoflavone that acts as a natural inhibitor of GSK-3β, potentially leading to the stabilization of transcription factors that enhance FOXD3 activity. | ||||||